Tipizzazione genetica nelle patologie HLA-correlate. Sviluppo di una app per il supporto diagnostico

Translated title of the contribution: Genotyping in patients affected by HLA-related diseases. App development for diagnostic support

Cristina Capittini, Chiara Rebuffi, Valeria Scotti, Dimitri Poddighe, Luca Mascaretti, Annamaria Pasi, Miryam Martinetti, Carmine Tinelli, Annalisa De Silvestri

Research output: Contribution to journalArticle

Abstract

HLA typing requests for association studies of immune-mediated diseases are often redundant and inadequate. We designed a series of meta-analyses to evaluate the accuracy of typing and distribution of HLA alleles predisposing to diseases, aiming at developing an app that can help doctors in choosing the most suitable molecular analysis. The first study was on celiac disease (CD) and HLA-DQ in children. We searched all english articles published in the main bibliographic databases up to May 2016. The search strategy has been developed using controlled terms (e.g. MeSH) and free terms. We identified 1885 articles. 1334 abstracts were examined. 46 manuscripts were evaluated, and 13 studies were included in the meta-analysis (740 CD and 943 controls). The risk of developing CD in children with allelic variants encoding the HLA-DQ2.5 and/or HLA-DQ8 molecules has been confirmed. The greatest CD risk resides in carriers of two DQ2.5 molecules, i.e. subjects homozygous for the DQB1∗02:01 and DQA1∗05 alleles (OR=5.4, 95 % CI=4.1-6.8) compared to any other DQ genotype. Carriers of two DQB1∗02:01 (chain β2) alleles and one DQA1∗05 (chain α5) allele have the same risk (p=0.8089) of DQ2.5 homozygotes (OR=5.3%, 95 CI=4,1 to 6.5). We found no differences between DQ8/β2 and DQ2.5/DQ8, nor between β2/DQX and DQ2.5/X. We suggest a two-step process: first typing the DQB1∗02:01 allele and, in case of a negative result, full typing of HLA-DQ.

Original languageItalian
Pages (from-to)124-126
Number of pages3
JournalRecenti Progressi in Medicina
Volume109
Issue number2
DOIs
Publication statusPublished - Feb 1 2018
Externally publishedYes

Fingerprint

Celiac Disease
Alleles
HLA-DQ Antigens
Histocompatibility Testing
Meta-Analysis
Bibliographic Databases
Manuscripts
Immune System Diseases
Homozygote
Genotype

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Tipizzazione genetica nelle patologie HLA-correlate. Sviluppo di una app per il supporto diagnostico. / Capittini, Cristina; Rebuffi, Chiara; Scotti, Valeria; Poddighe, Dimitri; Mascaretti, Luca; Pasi, Annamaria; Martinetti, Miryam; Tinelli, Carmine; De Silvestri, Annalisa.

In: Recenti Progressi in Medicina, Vol. 109, No. 2, 01.02.2018, p. 124-126.

Research output: Contribution to journalArticle

Capittini, C, Rebuffi, C, Scotti, V, Poddighe, D, Mascaretti, L, Pasi, A, Martinetti, M, Tinelli, C & De Silvestri, A 2018, 'Tipizzazione genetica nelle patologie HLA-correlate. Sviluppo di una app per il supporto diagnostico', Recenti Progressi in Medicina, vol. 109, no. 2, pp. 124-126. https://doi.org/10.1701/2865.28906
Capittini, Cristina ; Rebuffi, Chiara ; Scotti, Valeria ; Poddighe, Dimitri ; Mascaretti, Luca ; Pasi, Annamaria ; Martinetti, Miryam ; Tinelli, Carmine ; De Silvestri, Annalisa. / Tipizzazione genetica nelle patologie HLA-correlate. Sviluppo di una app per il supporto diagnostico. In: Recenti Progressi in Medicina. 2018 ; Vol. 109, No. 2. pp. 124-126.
@article{450f781c60534899aa7a5ef2107db3c7,
title = "Tipizzazione genetica nelle patologie HLA-correlate. Sviluppo di una app per il supporto diagnostico",
abstract = "HLA typing requests for association studies of immune-mediated diseases are often redundant and inadequate. We designed a series of meta-analyses to evaluate the accuracy of typing and distribution of HLA alleles predisposing to diseases, aiming at developing an app that can help doctors in choosing the most suitable molecular analysis. The first study was on celiac disease (CD) and HLA-DQ in children. We searched all english articles published in the main bibliographic databases up to May 2016. The search strategy has been developed using controlled terms (e.g. MeSH) and free terms. We identified 1885 articles. 1334 abstracts were examined. 46 manuscripts were evaluated, and 13 studies were included in the meta-analysis (740 CD and 943 controls). The risk of developing CD in children with allelic variants encoding the HLA-DQ2.5 and/or HLA-DQ8 molecules has been confirmed. The greatest CD risk resides in carriers of two DQ2.5 molecules, i.e. subjects homozygous for the DQB1∗02:01 and DQA1∗05 alleles (OR=5.4, 95 {\%} CI=4.1-6.8) compared to any other DQ genotype. Carriers of two DQB1∗02:01 (chain β2) alleles and one DQA1∗05 (chain α5) allele have the same risk (p=0.8089) of DQ2.5 homozygotes (OR=5.3{\%}, 95 CI=4,1 to 6.5). We found no differences between DQ8/β2 and DQ2.5/DQ8, nor between β2/DQX and DQ2.5/X. We suggest a two-step process: first typing the DQB1∗02:01 allele and, in case of a negative result, full typing of HLA-DQ.",
author = "Cristina Capittini and Chiara Rebuffi and Valeria Scotti and Dimitri Poddighe and Luca Mascaretti and Annamaria Pasi and Miryam Martinetti and Carmine Tinelli and {De Silvestri}, Annalisa",
year = "2018",
month = "2",
day = "1",
doi = "10.1701/2865.28906",
language = "Italian",
volume = "109",
pages = "124--126",
journal = "Recenti Progressi in Medicina",
issn = "0034-1193",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "2",

}

TY - JOUR

T1 - Tipizzazione genetica nelle patologie HLA-correlate. Sviluppo di una app per il supporto diagnostico

AU - Capittini, Cristina

AU - Rebuffi, Chiara

AU - Scotti, Valeria

AU - Poddighe, Dimitri

AU - Mascaretti, Luca

AU - Pasi, Annamaria

AU - Martinetti, Miryam

AU - Tinelli, Carmine

AU - De Silvestri, Annalisa

PY - 2018/2/1

Y1 - 2018/2/1

N2 - HLA typing requests for association studies of immune-mediated diseases are often redundant and inadequate. We designed a series of meta-analyses to evaluate the accuracy of typing and distribution of HLA alleles predisposing to diseases, aiming at developing an app that can help doctors in choosing the most suitable molecular analysis. The first study was on celiac disease (CD) and HLA-DQ in children. We searched all english articles published in the main bibliographic databases up to May 2016. The search strategy has been developed using controlled terms (e.g. MeSH) and free terms. We identified 1885 articles. 1334 abstracts were examined. 46 manuscripts were evaluated, and 13 studies were included in the meta-analysis (740 CD and 943 controls). The risk of developing CD in children with allelic variants encoding the HLA-DQ2.5 and/or HLA-DQ8 molecules has been confirmed. The greatest CD risk resides in carriers of two DQ2.5 molecules, i.e. subjects homozygous for the DQB1∗02:01 and DQA1∗05 alleles (OR=5.4, 95 % CI=4.1-6.8) compared to any other DQ genotype. Carriers of two DQB1∗02:01 (chain β2) alleles and one DQA1∗05 (chain α5) allele have the same risk (p=0.8089) of DQ2.5 homozygotes (OR=5.3%, 95 CI=4,1 to 6.5). We found no differences between DQ8/β2 and DQ2.5/DQ8, nor between β2/DQX and DQ2.5/X. We suggest a two-step process: first typing the DQB1∗02:01 allele and, in case of a negative result, full typing of HLA-DQ.

AB - HLA typing requests for association studies of immune-mediated diseases are often redundant and inadequate. We designed a series of meta-analyses to evaluate the accuracy of typing and distribution of HLA alleles predisposing to diseases, aiming at developing an app that can help doctors in choosing the most suitable molecular analysis. The first study was on celiac disease (CD) and HLA-DQ in children. We searched all english articles published in the main bibliographic databases up to May 2016. The search strategy has been developed using controlled terms (e.g. MeSH) and free terms. We identified 1885 articles. 1334 abstracts were examined. 46 manuscripts were evaluated, and 13 studies were included in the meta-analysis (740 CD and 943 controls). The risk of developing CD in children with allelic variants encoding the HLA-DQ2.5 and/or HLA-DQ8 molecules has been confirmed. The greatest CD risk resides in carriers of two DQ2.5 molecules, i.e. subjects homozygous for the DQB1∗02:01 and DQA1∗05 alleles (OR=5.4, 95 % CI=4.1-6.8) compared to any other DQ genotype. Carriers of two DQB1∗02:01 (chain β2) alleles and one DQA1∗05 (chain α5) allele have the same risk (p=0.8089) of DQ2.5 homozygotes (OR=5.3%, 95 CI=4,1 to 6.5). We found no differences between DQ8/β2 and DQ2.5/DQ8, nor between β2/DQX and DQ2.5/X. We suggest a two-step process: first typing the DQB1∗02:01 allele and, in case of a negative result, full typing of HLA-DQ.

UR - http://www.scopus.com/inward/record.url?scp=85042699077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042699077&partnerID=8YFLogxK

U2 - 10.1701/2865.28906

DO - 10.1701/2865.28906

M3 - Article

VL - 109

SP - 124

EP - 126

JO - Recenti Progressi in Medicina

JF - Recenti Progressi in Medicina

SN - 0034-1193

IS - 2

ER -